The global chicken offal market is expected to be valued at around US$ 1,024.5 Mn in 2023 and registered a Y-o-Y growth of 4.6% in the historic period. Chicken offal sales are projected to increase at a healthy CAGR of 9.2% and top a valuation of US$ 2,478 Mn by 2033.
Key Trends Listed by Future Market Insights (FMI):
Rise in health-conscious consumer base
Higher emphasis on incorporating chicken offal in balanced diets for essential nutrients
Substantial growth in exports and imports of poultry and its products
New facilities and new players in chicken production increasing capacity
The Soaring Popularity of Frozen Chicken Offal Products
Management of chicken offal as a part of poultry waste reduction
Poultry/Chicken offal for growing and finishing swine diets
Rising demand for value-added chicken offal products
Expansion of online retail and direct-to-consumer channels for chicken offal
Incorporation of chicken offal in pet food and animal feed products
A chicken’s internal organs and guts are known as chicken offal, sometimes known as variety meats. The term does not specifically refer to a list of edible organs; rather, it refers to the majority of internal organs, with the exception of muscle and bone, which vary by culture and geography. Chicken offal is also termed as Giblet. Giblets include the neck, liver, gizzards, skin, feet, wings, and intestine.
Chicken offal is recognized for its high nutritional value, being a good source of essential vitamins, minerals, and proteins. Consumers seeking nutrient-dense food options are turning to chicken offal for its nutritional benefits. Chicken offal holds importance in terms of its nutritional content, sustainability, and affordability. It contains essential nutrients like iron, zinc, vitamin B12, and folate, which are important for overall health and well-being. Furthermore, chicken offal is often more affordable compared to other meat cuts, making it an accessible and cost-effective source of protein for a wide range of consumers.
The organ chicken liver is gaining popularity because chicken liver is known to have a lighter inherent taste than beef, pork, and lamb livers. Although it is typically maroon in color but can have a yellowish tint if it is high in fat. It is slippery in texture in its raw state. Chicken liver is becoming a convenient choice for health-conscious people as it is a rich source of iron and protein and also it takes very little time to cook.
There has been a surge in both domestic and international trade of poultry and its products, including offal. This growing demand has led to the expansion of production facilities and the entry of new players in the chicken industry, increasing the availability of chicken offal in the market.
The rise of online retail and direct-to-consumer channels has made it easier for consumers to access a wide range of offal products and explore new culinary experiences. The influence of celebrity chefs, food influencers, and culinary trends has further propelled the popularity of chicken offal, with increased awareness and exposure to its culinary potential.
Chicken offal can also be used in the production of biofuels. For instance, a study has shown that a chicken plant could produce over 10,000 gallons of oil from offal and approximately 1,000 gallons from dissolved air flotation (DAF) skimming daily by very simple processes. It was then possible to convert this fat to biofuel for use in boilers and transport trucks because the fat was of very high quality.
Attributes
Key Insights
Estimated Global Chicken Offal Market Size (2023E)
US$ 1,024.6 million
Projected Chicken Offal Market Value (2033F)
US$ 2,478 million
Value-based CAGR (2023 to 2033)
9.2%
Top 3 Countries’ Value
US$ 453.8 million
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How Has the Market Progressed So Far in 2023?
Market Statistics
Details
Jan to Jun (H1), 2021 (A)
6.7%
Jul to Dec (H2), 2021 (A)
5.3%
Jan to Jun (H1), 2022 Projected (P)
7.0%
Jan to Jun (H1), 2022 Outlook (O)
7.4%
Jul to Dec (H2), 2022 Outlook (O)
6.0%
Jul to Dec (H2), 2022 Projected (P)
5.5%
Jan to Jun (H1), 2023 Projected (P)
8.8%
BPS Change: H1, 2022 (O) to H1, 2022 (P)
-30
BPS Change: H1, 2022 (O) to H1, 2021 (A)
70
BPS Change: H2, 2022 (O) to H2, 2022 (P)
-50
BPS Change: H2, 2022 (O) to H2, 2022 (A)
75.6
2018 to 2022 Global Chicken Offal Sales Outlook Compared to Demand Forecast from 2023 to 2033
According to the Future Market Insights (FMI) analysis, global chicken offal sales grew at a CAGR of 4.6% from 2018 to 2022. For the next ten years, the worldwide market for chicken offal is forecasted to progress at 9.2% CAGR.
It is essential to note that the demand for chicken offal is influenced by the factors such as cultural, culinary, and dietary considerations. Moreover, the demand is also affected by the rise in the health-conscious consumer base, rising interest in sustainable and ethical food choices, and the popularity of various cuisines.
Although chicken offal has historically been popular in some areas and cuisines, it’s adaptability and nutritional worth are now more widely acknowledged. The market for chicken offal has increased as more customers become aware of the nutritional advantages of offal and adopt a nose-to-tail eating philosophy.
The demand for chicken offal has also increased as a result of advancements in processing methods, culinary ingenuity, and the impact of celebrity chefs and food influencers. These elements have resulted in the development of novel offal-based products, inventive recipes, and a rise in the availability of offal in both retail and food service settings.
Find your sweet spots for generating winning opportunities in this market.
Adjacent Markets Overview
Fresh Organic Chicken:
Attributes
Fresh Organic Chicken
CAGR (2023 to 2033)
14.2%
Market Value (2033)
US$ 12.8 billion
Growth Factor
The availability of fresh organic chicken has expanded in retail outlets, including supermarkets, specialty stores, and online platforms.
Opportunity
Offering value-added products, such as organic chicken cuts, sausages, marinated options, and ready-to-cook meals, provides opportunities to diversify product offerings and cater to different consumer preferences.
Key Trends
Consumers are increasingly seeking locally sourced and direct-to-consumer options for fresh organic chicken. They prefer to purchase chicken directly from farmers' markets, farm stands, community-supported agriculture (CSA) programs, or through farm-to-table initiatives.
Organic Meat Market:
Attributes
Organic Meat Market
CAGR (2023 to 2033)
5.3%
Market Value (2033)
~US$ 30.7 billion
Growth Factor
The growth of the organic meat market is attributed to increasing consumer demand, health, and environmental awareness, expanded retail availability, premium pricing, market differentiation, and consumer perception of organic products.
Opportunity
Due to the greater expenses associated with organic farming methods, organic meat typically commands a higher premium than conventional meat. Suppliers and producers now have a chance to raise their profit margins and possibly even their overall profitability.
Key Trends
Consumers are looking for more transparency and traceability in the supply chain as demand for organic beef rises. They are curious about the origins of their meat, the methods used in its production, and how it was produced.
Processed Meat Market:
Attributes
Processed Meat Market
CAGR (2023 to 2033)
6.3%
Market Value (2033)
US$ 643.2 billion
Growth Factor
The growing food service and quick-service industry is fuelling the growth of the processed meat market.
Opportunity
There is ample opportunity for product innovation in the processed meat market. Businesses can develop new flavors, varieties, and packaging formats to cater to evolving consumer preferences and trends.
Key Trends
Healthy eating has encouraged several food industry participants to invest in cutting-edge technologies to mitigate the negative environmental effects of food production.
Country-wise Insights
Region
North America
Country
United States
CAGR
8.9%
BPS Analysis
-85
Market Value (2033)
US$ 572.4 million
Region
Europe
Country
United Kingdom
CAGR
5.6%
BPS Analysis
109
Market Value (2033)
US$ 227.9 million
Region
Europe
Country
Germany
CAGR
6.4%
BPS Analysis
78
Market Value (2033)
US$ 294.8 million
Region
Asia-Pacific
Country
India
CAGR
8.5%
BPS Analysis
190
Market Value (2033)
US$ 166.0 million
Region
Asia-Pacific
Country
Japan
CAGR
7.9%
BPS Analysis
146
Market Value (2033)
US$ 131.3 million
Region
Asia-Pacific
Country
Australia
CAGR
7.2%
BPS Analysis
134
Market Value (2033)
US$ 173.4 million
Will the USA Retain its Dominance in the North America Chicken Offal Market?
Increased Convenience Food Consumption is Driving Up Offal Sales in the USA
As per Future Market Insights, the United States Chicken offal market is expected to reach a valuation of around US$ 572.4 million by 2033. It will therefore hold a prominent value share of 25.6% in the North American market.
Increased convenience food consumption has an impact on offal sales in the USA It has robust poultry and processing infrastructure including advanced facilities and technologies. The country's extensive poultry production provides a consistent supply of chicken offal.
Due to the hectic lifestyles of many people and families in the United States, convenience food has grown in popularity. These pre-packaged foods are practical and time-saving solutions for quick meals because they need little preparation and are pre-packaged.
The availability and cost of chicken offal in comparison to popular chicken cuts are two major factors in the market's expansion for convenience foods. As opposed to chicken breasts or boneless thighs, offal such as chicken livers, gizzards, or hearts are frequently sold for a lower price. Offal is a desirable option since it allows manufacturers and makers of convenience foods to offer more reasonably priced products without sacrificing taste or quality.
What is Driving Chicken Offal Demand in Japan?
Rising Interest in Japanese Culinary Art Driving the Chicken Offal Market
According to FMI analysis, expanding at a CAGR of 7.9%, the chicken offal market in Japan is projected to increase from a market valuation of US$ 61.3 in 2023 to US$ 131.3 by 2033.
Japan is known for its culinary cuisines and new techniques. Japanese cuisine has become well-known and well-liked around the world for its quality, harmony, and reliance on fresh ingredients. It includes a wide variety of foods and preparation methods, including traditional street food, izakaya (Japanese gastropubs), and upscale kaiseki dining. Offal, or horumon in Japanese, has a specific position in this culinary world and is a key ingredient in many recipes.
For instance, Kimo or reba is a traditional Japanese yakitori-style (grilled skewered chicken) dish made with chicken liver as the main ingredient.
Japan's rich culinary heritage has been key in driving consumer interest in chicken offal, an often-overlooked delicacy. In its cuisine precision, balance, and high-quality fresh ingredients hold special significance that goes beyond the country’s borders. With Horumon (offal) occupies a critical niche within this tradition by featuring extensively throughout various dishes served across Japan.
Whether it be through yakitori (grilled skewered chicken), yakiniku (Japanese barbecue), or hot pot preparations outlining different cuts/ organs featured distinctly through each dish. Japan's rich culinary scene appeals globally owing to those who look forward to experiencing authentic culture-specific cooking techniques and tastes. Chefs worldwide are charmed by the exquisite taste & quality evident in preparing traditional Japanese cuisine.
What is the Demand Outlook for the Chicken Offal in Germany’s Market?
Increasing appreciation for diverse flavors and culinary experiences of Chicken Offal in Germany
Chicken Offal demand in Germany is anticipated to rise at a CAGR of 6.4% during the forecast period from 2023 to 2033. By the end of 2033, Germany is likely to hold a market share of 9.2% in the European market.
The perception and demand for chicken offal in Germany have risen as a result of the country's growing appreciation for a variety of flavors and culinary experiences. German consumers are adopting a greater variety of tastes, textures, and ingredients, including offal, as culinary frontiers continue to blur.
The rising popularity of diverse food is one of the main elements influencing this enthusiasm. German consumers are now more ambitious with their dining alternatives, looking for fresh and distinctive flavors from around the world. This gastronomic curiosity has opened doors to classic meals and methods of cooking that use chicken offal as a key ingredient. It has become easier to accept and appreciate the variety of flavors that offal brings to the table as a result of learning about other countries and their culinary traditions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which is the Most Consumed Organ as Chicken Offal?
Demand in the Market Remain High for Liver as Chicken Offal
Based on organ type, demand is expected to remain high for liver chicken offal during the assessment period. As per Future Market Insights, with a market share of around 31%, the liver chicken offal segment is projected to reach a valuation of US$ 802.4 million in 2033.
Chicken liver is widely known for its high nutritional value as it is regarded as a food that is densely packed with essential nutrients such as high-quality protein, amino acids, vitamins, and minerals. Due to the presence of nutrients like iron, vitamin A, vitamin B12, folate, and other B vitamins, chicken liver is considered a nutrient-dense food that is highly recommended for individuals who are looking to include nutrient-rich foods in their daily diet.
Chicken liver has a unique taste that appeals to many people. It has a rich, savory flavor with a slightly sweet undertone. Additionally, it has a smooth and tender texture that enhances the overall eating experience. The taste and texture of chicken liver make it an appealing choice for those seeking a rich and indulgent culinary experience.
Many people find chicken liver's taste quite distinctive and delicious. It has a deep, savory flavor profile that's complemented by a hint of sweetness. Furthermore, its velvety texture is pleasing to the palate, making every bite an enjoyable experience. Given its delectable taste and texture, chicken liver is a popular choice for those who crave indulgent and flavourful meals.
Why Dietary Supplements is Dominating the End-Use Segment?
Chicken Offal as a rich source of Minerals and Vitamins
The dietary supplement is estimated to dominate the End-use segment in terms of market share by holding 37% in 2023. The target segment is likely to reach a market value of US$ 878.6 million by the end of 2033.
Chicken offal is a good source of protein, vitamins, and minerals. It is also a good source of iron, zinc, and selenium. Chicken offal can be used as a dietary supplement to help improve overall health and well-being.
Chicken offal such as liver, hurts, lungs, kidneys, and blends are particularly rich in B vitamins, such as vitamin B12 and folate. They are also rich in important fat-soluble vitamins like vitamins A, D, E, and K. Owing to these applications in human health, chicken offal is gaining popularity as an important source of dietary supplement.
Competitive Landscape
There is an increase in the production of poultry meal and offal including chicken. The companies like Perdue Farms and Sanderson Farms are producing the offal on their own and selling it with premium packaging along with other organ products such as wings, legs, and breasts. Pet food companies such as Nature’s Farmacy and Primitive Choice are using chicken offal like liver and heart for the production of animal feed.
Scope of the Report
Attribute
Details
Market Size Value in 2023
US$ 1,024.6 million
Market Forecast Value in 2033
US$ 2,478 million
Anticipated Growth Rate (2023 to 2033)
9.2% CAGR
Forecast Period
2023 to 2033
Historical Data Available for
2018 to 2022
Market Analysis
Volume (MT) and Value (US$ Million)
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
Canada, United States, Mexico, Brazil, Chile, Peru, Argentina, Germany, France, Italy, Spain, United Kingdom, Netherlands, Belgium, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Central Africa, and others
Key Market Segments Covered
Organs, End-use, and Regions
Key Companies Profiled
Natures Farmacy
Primitive Choice
Little Warrior
Proliver
Knowde
IQI Petfood
The Good Scent Company
Herbpowders
PCCA
BNK Products
Baith Market
Lifeasible
Feline Instincts
Perdue Farms
Sanderson Farms
Brand-Pilgrim's Chicken
Foster Farms
Wayne Farms
Bell & Evans
Gold'n Plump
Kunhe & Heitz
Chicken Offal Market by Category
By Organ:
Kidneys
Hearts
Brain
Liver
Lungs
Blends
By End-use:
Food and Beverages
Dietary Supplements
Pet Food
Cosmetics and Personal Care
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Frequently Asked Questions
What is the Expected Revenue of Chicken Offal Market in 2023?
The chicken offal market is expected to generate revenue of US$ 1,024.6 million in 2023.
Which Factors are Pushing the Market Growth?
Increasing health-conscious consumer base and rising popularity of frozen chicken offal products.
Which Asian Country Enjoys Robust Market CAGR?
India has the robust market CAGR of 8.5% through 2033.
How Did the Market Perform in the Historical Period?
The market expanded at a CAGR of 4.6% in the historical period.
Which is the Significantly Consumed Organ as Chicken Offal?
Liver is expected to be a prominently consumed organ as a chicken offal.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market Trends by Region
3.5. Macro-Economic Factors
3.6. Forecast Factors - Relevance & Impact
4. Global Market - Pricing Analysis
4.1. Price Point Assessment by Region
4.1.1. Manufacturer-Level Pricing
4.1.2. Distributor Level Pricing
4.2. Price Point Assessment by Organ
4.3. Price Influencing Factors
5. Value Chain Analysis
5.1. Operating margins at each node of the supply chain
5.2. List of Active Market Participants
5.2.1. Product Manufacturers
5.2.2. End Users
6. Global Market Demand (in Value (US$ Million) and Volume (MT) Analysis 2018 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Value (US$ Million) and Volume (MT) Analysis, 2018 to 2022
6.2. Current and Future Market Value (US$ Million) and Volume (MT) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Organ
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) and Volume (MT) Analysis by Organ, 2018 to 2022
7.3. Current and Future Market Size (US$ Million) and Volume (MT) Analysis and Forecast by Organ, 2023 to 2033
7.3.1. Kidneys
7.3.2. Hearts
7.3.3. Brain
7.3.4. Liver
7.3.5. Lungs
7.3.6. Blends
7.4. Market Attractiveness Analysis by Organ
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) and Volume (MT) Analysis by End-Use, 2018 to 2022
8.3. Current and Future Market Size (US$ Million) and Volume (MT) Analysis and Forecast by End-Use, 2023 to 2033
8.3.1. Food and Beverages
8.3.2. Dietary Supplements
8.3.3. Pet Food
8.3.4. Cosmetics and Personal Care
8.4. Market Attractiveness Analysis by End-Use
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size (US$ Million) and Volume (MT) Analysis by Region, 2018 to 2022
9.3. Current Market Size (US$ Million) and Volume (MT) Analysis and Forecast by Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. Middle East & Africa
9.4. Market Attractiveness Analysis by Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
10.1. Introduction
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
10.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
10.4.1. By Country
10.4.1.1. USA
10.4.1.2. Canada
10.4.2. By Organ
10.4.3. By End-Use
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Organ
10.5.3. By End-Use
10.6. Market Trends
10.7. Key Market Participants - Intensity Mapping
10.8. Drivers and Restraints - Impact Analysis
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
11.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
11.4.1. By Country
11.4.1.1. Brazil
11.4.1.2. Mexico
11.4.1.3. Argentina
11.4.1.4. Rest of Latin America
11.4.2. By Organ
11.4.3. By End-Use
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Organ
11.5.3. By End-Use
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
12.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
12.4.1. By Country
12.4.1.1. Germany
12.4.1.2. UK
12.4.1.3. France
12.4.1.4. Italy
12.4.1.5. Spain
12.4.1.6. BENELUX
12.4.1.7. Nordic
12.4.1.8. Russia
12.4.1.9. Poland
12.4.1.10. Rest of Europe
12.4.2. By Organ
12.4.3. By End-Use
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Organ
12.5.3. By End-Use
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
13.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
13.4.1. By Country
13.4.1.1. China
13.4.1.2. Japan
13.4.1.3. South Korea
13.4.2. By Organ
13.4.3. By End-Use
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Organ
13.5.3. By End-Use
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
14.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. India
14.4.1.2. Thailand
14.4.1.3. Malaysia
14.4.1.4. Indonesia
14.4.1.5. Vietnam
14.4.1.6. Philippines
14.4.1.7. Singapore
14.4.1.8. Rest of South Asia
14.4.2. By Organ
14.4.3. By End-Use
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Organ
14.5.3. By End-Use
14.6. By Sales Channel Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
15.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. Australia
15.4.1.2. New Zealand
15.4.2. By Organ
15.4.3. By End-Use
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Organ
15.5.3. By End-Use
15.6. By Sales Channel Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
16.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. Turkey
16.4.1.3. Egypt
16.4.1.4. South Africa
16.4.1.5. Rest of MEA
16.4.2. By Organ
16.4.3. By End-Use
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Organ
16.5.3. By End-Use
16.6. By Sales Channel Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Country-level Market Analysis
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. USA Market Analysis
17.2.1. By Organ
17.2.2. By End-Use
17.3. Canada Market Analysis
17.3.1. By Organ
17.3.2. By End-Use
17.4. Brazil Market Analysis
17.4.1. By Organ
17.4.2. By End-Use
17.5. Mexico Market Analysis
17.5.1. By Organ
17.5.2. By End-Use
17.6. Argentina Market Analysis
17.6.1. By Organ
17.6.2. By End-Use
17.7. Germany Market Analysis
17.7.1. By Organ
17.7.2. By End-Use
17.8. UK Market Analysis
17.8.1. By Organ
17.8.2. By End-Use
17.9. France Market Analysis
17.9.1. By Organ
17.9.2. By End-Use
17.10. Italy Market Analysis
17.10.1. By Organ
17.10.2. By End-Use
17.11. Spain Market Analysis
17.11.1. By Organ
17.11.2. By End-Use
17.12. BENELUX Europe Market Analysis
17.12.1. By Organ
17.12.2. By End-Use
17.13. Nordic Market Analysis
17.13.1. By Organ
17.13.2. By End-Use
17.14. Russia Region Market Analysis
17.14.1. By Organ
17.14.2. By End-Use
17.15. Poland Market Analysis
17.15.1. By Organ
17.15.2. By End-Use
17.16. China Market Analysis
17.16.1. By Organ
17.16.2. By End-Use
17.17. Japan Market Analysis
17.17.1. By Organ
17.17.2. By End-Use
17.18. India Market Analysis
17.18.1. By Organ
17.18.2. By End-Use
17.19. Thailand Market Analysis
17.19.1. By Organ
17.19.2. By End-Use
17.20. Malaysia Market Analysis
17.20.1. By Organ
17.20.2. By End-Use
17.21. Indonesia Market Analysis
17.21.1. By Organ
17.21.2. By End-Use
17.22. Vietnam Market Analysis
17.22.1. By Organ
17.22.2. By End-Use
17.23. Philippines Market Analysis
17.23.1. By Organ
17.23.2. By End-Use
17.24. Singapore Market Analysis
17.24.1. By Organ
17.24.2. By End-Use
17.25. Australia Market Analysis
17.25.1. By Organ
17.25.2. By End-Use
17.26. New Zealand Market Analysis
17.26.1. By Organ
17.26.2. By End-Use
17.27. GCC Countries Market Analysis
17.27.1. By Organ
17.27.2. By End-Use
17.28. South Africa Market Analysis
17.28.1. By Organ
17.28.2. By End-Use
17.29. Central Africa Market Analysis
17.29.1. By Organ
17.29.2. By End-Use
18. Market Structure Analysis
18.1. Global Market Competition - a Dashboard View
18.2. Global Market Structure Analysis
18.3. Global Market Company Share Analysis
18.3.1. For Tier 1 Market Players, 2022
18.3.2. Company Market Share Analysis of Top 5 Players, By Region
18.4. Key Participants Market Presence (Intensity Mapping) By Region
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Deep Dive
19.2.1. Natures Farmacy
19.2.1.1. Product Portfolio
19.2.1.2. Revenue by Market Segments (Product/Channel/Region)
19.2.1.3. Sales Footprint
19.2.1.4. Strategy Overview
19.2.1.4.1. Marketing Strategy
19.2.1.4.2. Product Strategy
19.2.1.4.3. Channel Strategy
19.2.2. Primitive Choice
19.2.2.1. Product Portfolio
19.2.2.2. Revenue by Market Segments (Product/Channel/Region)
19.2.2.3. Sales Footprint
19.2.2.4. Strategy Overview
19.2.2.4.1. Marketing Strategy
19.2.2.4.2. Product Strategy
19.2.2.4.3. Channel Strategy
19.2.3. Little Warrior
19.2.3.1. Product Portfolio
19.2.3.2. Revenue by Market Segments (Product/Channel/Region)
19.2.3.3. Sales Footprint
19.2.3.4. Strategy Overview
19.2.3.4.1. Marketing Strategy
19.2.3.4.2. Product Strategy
19.2.3.4.3. Channel Strategy
19.2.4. Proliver
19.2.4.1. Product Portfolio
19.2.4.2. Revenue by Market Segments (Product/Channel/Region)
19.2.4.3. Sales Footprint
19.2.4.4. Strategy Overview
19.2.4.4.1. Marketing Strategy
19.2.4.4.2. Product Strategy
19.2.4.4.3. Channel Strategy
19.2.5. Knowde
19.2.5.1. Product Portfolio
19.2.5.2. Revenue by Market Segments (Product/Channel/Region)
19.2.5.3. Sales Footprint
19.2.5.4. Strategy Overview
19.2.5.4.1. Marketing Strategy
19.2.5.4.2. Product Strategy
19.2.5.4.3. Channel Strategy
19.2.6. IQI Petfood
19.2.6.1. Product Portfolio
19.2.6.2. Revenue by Market Segments (Product/Channel/Region)
19.2.6.3. Sales Footprint
19.2.6.4. Strategy Overview
19.2.6.4.1. Marketing Strategy
19.2.6.4.2. Product Strategy
19.2.6.4.3. Channel Strategy
19.2.7. The Good Scent Company
19.2.7.1. Product Portfolio
19.2.7.2. Revenue by Market Segments (Product/Channel/Region)
19.2.7.3. Sales Footprint
19.2.7.4. Strategy Overview
19.2.7.4.1. Marketing Strategy
19.2.7.4.2. Product Strategy
19.2.7.4.3. Channel Strategy
19.2.8. Herbpowders
19.2.8.1. Product Portfolio
19.2.8.2. Revenue by Market Segments (Product/Channel/Region)
19.2.8.3. Sales Footprint
19.2.8.4. Strategy Overview
19.2.8.4.1. Marketing Strategy
19.2.8.4.2. Product Strategy
19.2.8.4.3. Channel Strategy
19.2.9. PCCA
19.2.9.1. Product Portfolio
19.2.9.2. Revenue by Market Segments (Product/Channel/Region)
19.2.9.3. Sales Footprint
19.2.9.4. Strategy Overview
19.2.9.4.1. Marketing Strategy
19.2.9.4.2. Product Strategy
19.2.9.4.3. Channel Strategy
19.2.10. BNK Products
19.2.10.1. Product Portfolio
19.2.10.2. Revenue by Market Segments (Product/Channel/Region)
19.2.10.3. Sales Footprint
19.2.10.4. Strategy Overview
19.2.10.4.1. Marketing Strategy
19.2.10.4.2. Product Strategy
19.2.10.4.3. Channel Strategy
19.2.11. Baith Market
19.2.11.1. Product Portfolio
19.2.11.2. Revenue by Market Segments (Product/Channel/Region)
19.2.11.3. Sales Footprint
19.2.11.4. Strategy Overview
19.2.11.4.1. Marketing Strategy
19.2.11.4.2. Product Strategy
19.2.11.4.3. Channel Strategy
19.2.12. Lifeasible
19.2.12.1. Product Portfolio
19.2.12.2. Revenue by Market Segments (Product/Channel/Region)
19.2.12.3. Sales Footprint
19.2.12.4. Strategy Overview
19.2.12.4.1. Marketing Strategy
19.2.12.4.2. Product Strategy
19.2.12.4.3. Channel Strategy
19.2.13. Feline Instincts
19.2.13.1. Product Portfolio
19.2.13.2. Revenue by Market Segments (Product/Channel/Region)
19.2.13.3. Sales Footprint
19.2.13.4. Strategy Overview
19.2.13.4.1. Marketing Strategy
19.2.13.4.2. Product Strategy
19.2.13.4.3. Channel Strategy
19.2.14. Perdue Farms
19.2.14.1. Product Portfolio
19.2.14.2. Revenue by Market Segments (Product/Channel/Region)
19.2.14.3. Sales Footprint
19.2.14.4. Strategy Overview
19.2.14.4.1. Marketing Strategy
19.2.14.4.2. Product Strategy
19.2.14.4.3. Channel Strategy
19.2.15. Sanderson Farms
19.2.15.1. Product Portfolio
19.2.15.2. Revenue by Market Segments (Product/Channel/Region)
19.2.15.3. Sales Footprint
19.2.15.4. Strategy Overview
19.2.15.4.1. Marketing Strategy
19.2.15.4.2. Product Strategy
19.2.15.4.3. Channel Strategy
19.2.16. Brand-Pilgrim's Chicken
19.2.16.1. Product Portfolio
19.2.16.2. Revenue by Market Segments (Product/Channel/Region)
19.2.16.3. Sales Footprint
19.2.16.4. Strategy Overview
19.2.16.4.1. Marketing Strategy
19.2.16.4.2. Product Strategy
19.2.16.4.3. Channel Strategy
19.2.17. Foster Farms
19.2.17.1. Product Portfolio
19.2.17.2. Revenue by Market Segments (Product/Channel/Region)
19.2.17.3. Sales Footprint
19.2.17.4. Strategy Overview
19.2.17.4.1. Marketing Strategy
19.2.17.4.2. Product Strategy
19.2.17.4.3. Channel Strategy
19.2.18. Wayne Farms
19.2.18.1. Product Portfolio
19.2.18.2. Revenue by Market Segments (Product/Channel/Region)
19.2.18.3. Sales Footprint
19.2.18.4. Strategy Overview
19.2.18.4.1. Marketing Strategy
19.2.18.4.2. Product Strategy
19.2.18.4.3. Channel Strategy
19.2.19. Bell & Evans
19.2.19.1. Product Portfolio
19.2.19.2. Revenue by Market Segments (Product/Channel/Region)
19.2.19.3. Sales Footprint
19.2.19.4. Strategy Overview
19.2.19.4.1. Marketing Strategy
19.2.19.4.2. Product Strategy
19.2.19.4.3. Channel Strategy
19.2.20. Gold'n Plump
19.2.20.1. Product Portfolio
19.2.20.2. Revenue by Market Segments (Product/Channel/Region)
19.2.20.3. Sales Footprint
19.2.20.4. Strategy Overview
19.2.20.4.1. Marketing Strategy
19.2.20.4.2. Product Strategy
19.2.20.4.3. Channel Strategy
19.2.21. Kunhe & Heitz
19.2.21.1. Product Portfolio
19.2.21.2. Revenue by Market Segments (Product/Channel/Region)
19.2.21.3. Sales Footprint
19.2.21.4. Strategy Overview
19.2.21.4.1. Marketing Strategy
19.2.21.4.2. Product Strategy
19.2.21.4.3. Channel Strategy
19.2.22. Other Players (On Additional Requests)
19.2.22.1. Product Portfolio
19.2.22.2. Revenue by Market Segments (Product/Channel/Region)
19.2.22.3. Sales Footprint
19.2.22.4. Strategy Overview
19.2.22.4.1. Marketing Strategy
19.2.22.4.2. Product Strategy
19.2.22.4.3. Channel Strategy
20. Assumptions and Acronyms Used21. Research Methodology
List of Tables
Table 1: Global Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Volume (MT) Forecast by Region, 2017 to 2032
Table 3: Global Value (US$ Million) Forecast by Organ, 2017 to 2032
Table 4: Global Volume (MT) Forecast by Organ, 2017 to 2032
Table 5: Global Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 6: Global Volume (MT) Forecast by End-use, 2017 to 2032
Table 7: North America Value (US$ Million) Forecast by Country, 2017 to 2032
Table 8: North America Volume (MT) Forecast by Country, 2017 to 2032
Table 9: North America Value (US$ Million) Forecast by Organ, 2017 to 2032
Table 10: North America Volume (MT) Forecast by Organ, 2017 to 2032
Table 11: North America Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 12: North America Volume (MT) Forecast by End-use, 2017 to 2032
Table 13: Latin America Value (US$ Million) Forecast by Country, 2017 to 2032
Table 14: Latin America Volume (MT) Forecast by Country, 2017 to 2032
Table 15: Latin America Value (US$ Million) Forecast by Organ, 2017 to 2032
Table 16: Latin America Volume (MT) Forecast by Organ, 2017 to 2032
Table 17: Latin America Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 18: Latin America Volume (MT) Forecast by End-use, 2017 to 2032
Table 19: Europe Value (US$ Million) Forecast by Country, 2017 to 2032
Table 20: Europe Volume (MT) Forecast by Country, 2017 to 2032
Table 21: Europe Value (US$ Million) Forecast by Organ, 2017 to 2032
Table 22: Europe Volume (MT) Forecast by Organ, 2017 to 2032
Table 23: Europe Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 24: Europe Volume (MT) Forecast by End-use, 2017 to 2032
Table 25: East Asia Value (US$ Million) Forecast by Country, 2017 to 2032
Table 26: East Asia Volume (MT) Forecast by Country, 2017 to 2032
Table 27: East Asia Value (US$ Million) Forecast by Organ, 2017 to 2032
Table 28: East Asia Volume (MT) Forecast by Organ, 2017 to 2032
Table 29: East Asia Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 30: East Asia Volume (MT) Forecast by End-use, 2017 to 2032
Table 31: South Asia Value (US$ Million) Forecast by Country, 2017 to 2032
Table 32: South Asia Volume (MT) Forecast by Country, 2017 to 2032
Table 33: South Asia Value (US$ Million) Forecast by Organ, 2017 to 2032
Table 34: South Asia Volume (MT) Forecast by Organ, 2017 to 2032
Table 35: South Asia Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 36: South Asia Volume (MT) Forecast by End-use, 2017 to 2032
Table 37: Oceania Value (US$ Million) Forecast by Country, 2017 to 2032
Table 38: Oceania Volume (MT) Forecast by Country, 2017 to 2032
Table 39: Oceania Value (US$ Million) Forecast by Organ, 2017 to 2032
Table 40: Oceania Volume (MT) Forecast by Organ, 2017 to 2032
Table 41: Oceania Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 42: Oceania Volume (MT) Forecast by End-use, 2017 to 2032
Table 43: MEA Value (US$ Million) Forecast by Country, 2017 to 2032
Table 44: MEA Volume (MT) Forecast by Country, 2017 to 2032
Table 45: MEA Value (US$ Million) Forecast by Organ, 2017 to 2032
Table 46: MEA Volume (MT) Forecast by Organ, 2017 to 2032
Table 47: MEA Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 48: MEA Volume (MT) Forecast by End-use, 2017 to 2032
List of Charts
Figure 1: Global Value (US$ Million) by Organ, 2022 to 2032
Figure 2: Global Value (US$ Million) by End-use, 2022 to 2032
Figure 3: Global Value (US$ Million) by Region, 2022 to 2032
Figure 4: Global Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 5: Global Volume (MT) Analysis by Region, 2017 to 2032
Figure 6: Global Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 7: Global Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 8: Global Value (US$ Million) Analysis by Organ, 2017 to 2032
Figure 9: Global Volume (MT) Analysis by Organ, 2017 to 2032
Figure 10: Global Value Share (%) and BPS Analysis by Organ, 2022 to 2032
Figure 11: Global Y-o-Y Growth (%) Projections by Organ, 2022 to 2032
Figure 12: Global Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 13: Global Volume (MT) Analysis by End-use, 2017 to 2032
Figure 14: Global Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 15: Global Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 16: Global Attractiveness by Organ, 2022 to 2032
Figure 17: Global Attractiveness by End-use, 2022 to 2032
Figure 18: Global Attractiveness by Region, 2022 to 2032
Figure 19: North America Value (US$ Million) by Organ, 2022 to 2032
Figure 20: North America Value (US$ Million) by End-use, 2022 to 2032
Figure 21: North America Value (US$ Million) by Country, 2022 to 2032
Figure 22: North America Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 23: North America Volume (MT) Analysis by Country, 2017 to 2032
Figure 24: North America Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 25: North America Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 26: North America Value (US$ Million) Analysis by Organ, 2017 to 2032
Figure 27: North America Volume (MT) Analysis by Organ, 2017 to 2032
Figure 28: North America Value Share (%) and BPS Analysis by Organ, 2022 to 2032
Figure 29: North America Y-o-Y Growth (%) Projections by Organ, 2022 to 2032
Figure 30: North America Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 31: North America Volume (MT) Analysis by End-use, 2017 to 2032
Figure 32: North America Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 33: North America Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 34: North America Attractiveness by Organ, 2022 to 2032
Figure 35: North America Attractiveness by End-use, 2022 to 2032
Figure 36: North America Attractiveness by Country, 2022 to 2032
Figure 37: Latin America Value (US$ Million) by Organ, 2022 to 2032
Figure 38: Latin America Value (US$ Million) by End-use, 2022 to 2032
Figure 39: Latin America Value (US$ Million) by Country, 2022 to 2032
Figure 40: Latin America Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 41: Latin America Volume (MT) Analysis by Country, 2017 to 2032
Figure 42: Latin America Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 43: Latin America Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 44: Latin America Value (US$ Million) Analysis by Organ, 2017 to 2032
Figure 45: Latin America Volume (MT) Analysis by Organ, 2017 to 2032
Figure 46: Latin America Value Share (%) and BPS Analysis by Organ, 2022 to 2032
Figure 47: Latin America Y-o-Y Growth (%) Projections by Organ, 2022 to 2032
Figure 48: Latin America Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 49: Latin America Volume (MT) Analysis by End-use, 2017 to 2032
Figure 50: Latin America Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 51: Latin America Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 52: Latin America Attractiveness by Organ, 2022 to 2032
Figure 53: Latin America Attractiveness by End-use, 2022 to 2032
Figure 54: Latin America Attractiveness by Country, 2022 to 2032
Figure 55: Europe Value (US$ Million) by Organ, 2022 to 2032
Figure 56: Europe Value (US$ Million) by End-use, 2022 to 2032
Figure 57: Europe Value (US$ Million) by Country, 2022 to 2032
Figure 58: Europe Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 59: Europe Volume (MT) Analysis by Country, 2017 to 2032
Figure 60: Europe Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 61: Europe Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 62: Europe Value (US$ Million) Analysis by Organ, 2017 to 2032
Figure 63: Europe Volume (MT) Analysis by Organ, 2017 to 2032
Figure 64: Europe Value Share (%) and BPS Analysis by Organ, 2022 to 2032
Figure 65: Europe Y-o-Y Growth (%) Projections by Organ, 2022 to 2032
Figure 66: Europe Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 67: Europe Volume (MT) Analysis by End-use, 2017 to 2032
Figure 68: Europe Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 69: Europe Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 70: Europe Attractiveness by Organ, 2022 to 2032
Figure 71: Europe Attractiveness by End-use, 2022 to 2032
Figure 72: Europe Attractiveness by Country, 2022 to 2032
Figure 73: East Asia Value (US$ Million) by Organ, 2022 to 2032
Figure 74: East Asia Value (US$ Million) by End-use, 2022 to 2032
Figure 75: East Asia Value (US$ Million) by Country, 2022 to 2032
Figure 76: East Asia Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 77: East Asia Volume (MT) Analysis by Country, 2017 to 2032
Figure 78: East Asia Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 79: East Asia Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 80: East Asia Value (US$ Million) Analysis by Organ, 2017 to 2032
Figure 81: East Asia Volume (MT) Analysis by Organ, 2017 to 2032
Figure 82: East Asia Value Share (%) and BPS Analysis by Organ, 2022 to 2032
Figure 83: East Asia Y-o-Y Growth (%) Projections by Organ, 2022 to 2032
Figure 84: East Asia Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 85: East Asia Volume (MT) Analysis by End-use, 2017 to 2032
Figure 86: East Asia Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 87: East Asia Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 88: East Asia Attractiveness by Organ, 2022 to 2032
Figure 89: East Asia Attractiveness by End-use, 2022 to 2032
Figure 90: East Asia Attractiveness by Country, 2022 to 2032
Figure 91: South Asia Value (US$ Million) by Organ, 2022 to 2032
Figure 92: South Asia Value (US$ Million) by End-use, 2022 to 2032
Figure 93: South Asia Value (US$ Million) by Country, 2022 to 2032
Figure 94: South Asia Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 95: South Asia Volume (MT) Analysis by Country, 2017 to 2032
Figure 96: South Asia Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 97: South Asia Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 98: South Asia Value (US$ Million) Analysis by Organ, 2017 to 2032
Figure 99: South Asia Volume (MT) Analysis by Organ, 2017 to 2032
Figure 100: South Asia Value Share (%) and BPS Analysis by Organ, 2022 to 2032
Figure 101: South Asia Y-o-Y Growth (%) Projections by Organ, 2022 to 2032
Figure 102: South Asia Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 103: South Asia Volume (MT) Analysis by End-use, 2017 to 2032
Figure 104: South Asia Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 105: South Asia Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 106: South Asia Attractiveness by Organ, 2022 to 2032
Figure 107: South Asia Attractiveness by End-use, 2022 to 2032
Figure 108: South Asia Attractiveness by Country, 2022 to 2032
Figure 109: Oceania Value (US$ Million) by Organ, 2022 to 2032
Figure 110: Oceania Value (US$ Million) by End-use, 2022 to 2032
Figure 111: Oceania Value (US$ Million) by Country, 2022 to 2032
Figure 112: Oceania Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 113: Oceania Volume (MT) Analysis by Country, 2017 to 2032
Figure 114: Oceania Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 115: Oceania Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 116: Oceania Value (US$ Million) Analysis by Organ, 2017 to 2032
Figure 117: Oceania Volume (MT) Analysis by Organ, 2017 to 2032
Figure 118: Oceania Value Share (%) and BPS Analysis by Organ, 2022 to 2032
Figure 119: Oceania Y-o-Y Growth (%) Projections by Organ, 2022 to 2032
Figure 120: Oceania Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 121: Oceania Volume (MT) Analysis by End-use, 2017 to 2032
Figure 122: Oceania Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 123: Oceania Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 124: Oceania Attractiveness by Organ, 2022 to 2032
Figure 125: Oceania Attractiveness by End-use, 2022 to 2032
Figure 126: Oceania Attractiveness by Country, 2022 to 2032
Figure 127: MEA Value (US$ Million) by Organ, 2022 to 2032
Figure 128: MEA Value (US$ Million) by End-use, 2022 to 2032
Figure 129: MEA Value (US$ Million) by Country, 2022 to 2032
Figure 130: MEA Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 131: MEA Volume (MT) Analysis by Country, 2017 to 2032
Figure 132: MEA Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 133: MEA Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 134: MEA Value (US$ Million) Analysis by Organ, 2017 to 2032
Figure 135: MEA Volume (MT) Analysis by Organ, 2017 to 2032
Figure 136: MEA Value Share (%) and BPS Analysis by Organ, 2022 to 2032
Figure 137: MEA Y-o-Y Growth (%) Projections by Organ, 2022 to 2032
Figure 138: MEA Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 139: MEA Volume (MT) Analysis by End-use, 2017 to 2032
Figure 140: MEA Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 141: MEA Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 142: MEA Attractiveness by Organ, 2022 to 2032
Figure 143: MEA Attractiveness by End-use, 2022 to 2032
Figure 144: MEA Attractiveness by Country, 2022 to 2032
